{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "GE", "item": "https://www.patentleaderboard.com/company/ge"}, {"@type": "ListItem", "position": 3, "name": "Thomas E. Jenkins", "item": "https://www.patentleaderboard.com/inventor/fl:th_ln:jenkins-4"}]}

Home › GE › Thomas E. Jenkins

TJ

Thomas E. Jenkins — 97 Patents

GE: 26 patents #900 of 36,430Top 3%

STSignature Therapeutics: 24 patents #1 of 5Top 20%

THTheravance: 16 patents #32 of 116Top 30%

ETElysium Therapeutics: 8 patents #1 of 2Top 50%

APAxys Pharmaceuticals: 6 patents #2 of 111Top 2%

AMAdvanced Medicine: 4 patents #3 of 34Top 9%

University of California: 3 patents #2,984 of 18,278Top 20%

RTX (Raytheon): 3 patents #3,886 of 15,912Top 25%

ESElf Atochem S.A.: 1 patents #238 of 505Top 50%

APArris Pharmaceutical: 1 patents #12 of 32Top 40%

Rue de l'Église, CA: #4 of 378 inventorsTop 2%

California: #2,402 of 386,348 inventorsTop 1%

Overall (All Time): #15,415 of 4,157,543Top 1%

97 Patents All Time

Thomas E. Jenkins has been granted 97 US patents while listed as an inventor at GE. The first was granted in 1980 and the most recent in August 2022. Thomas E. Jenkins ranks #15,415 of 4,157,543 US inventors in our database (top 0.37%). Patent records list Thomas E. Jenkins in Rue de l'Église, CA, US.

Patents per Year

Issued Patents All Time

Showing 1–25 of 97 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11400062	Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof	Craig Husfeld, Julie D. Seroogy, Jonathan W. Wray	2022-08-02
11318132	Diversion-resistant opioid formulations	—	2022-05-03
11197933	Polysubunit opioid prodrugs resistant to overdose and abuse	Craig Husfeld	2021-12-14
11179355	Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof	Craig Husfeld, Julie D. Seroogy, Jonathan W. Wray	2021-11-23
11154549	Opioid compositions resistant to overdose and abuse	—	2021-10-26
11129825	Polysubunit opioid prodrugs resistant to overdose and abuse	—	2021-09-28
10335406	Opioid compositions resistant to overdose and abuse	—	2019-07-02
10314839	Diversion-resistant opioid formulations	—	2019-06-11
10251878	Polysubunit opioid prodrugs resistant to overdose and abuse	—	2019-04-09
10028945	Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof	Craig Husfeld, Julie D. Seroogy, Jonathan W. Wray	2018-07-24
9808452	Polysubunit opioid prodrugs resistant to overdose and abuse	—	2017-11-07
9585963	Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof	Craig Husfeld, Julie D. Seroogy, Jonathan W. Wray	2017-03-07
9534014	Pharmaceutical compositions with attenuated release of phenolic opioids	Julie D. Seroogy, Jonathan W. Wray	2017-01-03
9499581	Compositions comprising enzyme-cleavable oxycodone prodrug	Craig Husfeld	2016-11-22
9493477	Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof	Craig Husfeld, Julie D. Seroogy, Jonathan W. Wray	2016-11-15
9238020	Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug	Julie D. Seroogy, Jonathan W. Wray	2016-01-19
9139612	Active agent prodrugs with heterocyclic linkers	Craig Husfeld	2015-09-22
9095627	Opioid prodrugs with heterocyclic linkers	Craig Husfeld	2015-08-04
9040032	Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof	Craig Husfeld, Julie D. Seroogy, Jonathan W. Wray	2015-05-26
9023860	Pro-drugs for controlled release of biologically active compounds	—	2015-05-05
8962547	Compositions comprising enzyme-cleavable oxycodone prodrug	Craig Husfeld	2015-02-24
8921418	Controlled release of phenolic opioids	Aleksandr Kolesnikov	2014-12-30
8871815	Therapeutic compounds	—	2014-10-28
8802681	Pharmaceutical compositions with attenuated release of phenolic opioids	Julie D. Seroogy, Jonathan W. Wray	2014-08-12
8685916	Opioid prodrugs with heterocyclic linkers	Craig Husfeld	2014-04-01